Share This Page:   

 

Browse by Clinical Topic:
Select a Topic to Learn More

Featured CME/CE Content:

 

neuroscienceCME Editors' Picks:

Collaborative Care Strategies for Reducing Hospital Readmissions in Patients with Heart Failure with Reduced Ejection Fraction

Premiere Date: Monday, March 27, 2017

This activity offers CE credit for:

1. Physicians (CME)
2. Pharmacists (ACPE)
3. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date:
Tuesday, March 27, 2018
Note: Credit Is No Longer Available

Faculty

Joseph O. Lambert, MD  Medical Director, Innovative Infusions Sub Investigator, North Hills Medical Research, Inc. President, North Hills Family Medicine Quality Committee Member, Catalyst Health Network North Richland Hills, TX

Bradley M. Leonard, MD, MBA, FACC  Managing Partner Advanced Heart Care Chief, Division of Cardiovascular Services Wise Health System Dallas, TX

Statement of Need

Heart failure (HF) is a chronic condition that requires long-term commitment on the part of the patient in adhering to an often-complex therapeutic and monitoring regimen, including lifestyle modifications and pharmacotherapy, and on the part of the clinician in maintaining knowledge of the most current therapies and devices to maximize efficacy, minimize side effects, improve monitoring, and reduce hospital readmissions. New treatments and technology have shown promise in improving outcomes in patients with heart failure, however compliance with treatment as a result of lifestyle, cost, and communication barriers, as well as monitoring heart failure symptoms at home remains burdensome for some patients and caregivers. These factors can contribute to hospital readmissions. The entire heart failure team must be involved and strategize with patients to reduce readmission rates and keep patients stable.

This CME Outfitters Snack features expert faculty presenting the rationale and evidence for the most up-to-date treatment and monitoring strategies for their patients with heart failure to improve quality of life and collaborative care strategies to decrease hospital readmissions.

Learning Objectives

At the end of this CE activity, participants should be able to:

• Examine the use of novel drug therapies and cardiac and monitoring devices to improve clinical outcomes in patients with heart failure with reduced ejection fraction.
• Apply collaborative care strategies to reduce hospital readmissions in patients with heart failure with reduced ejection fraction.

Financial Support

This activity is supported by educational funding provided by Amgen, Novartis Pharmaceuticals Corporation and St. Jude Medical, Inc.

Target Audience

Cardiologists, internists, primary care physicians, physician assistants, nurse practitioners, pharmacists, and other healthcare professionals with an interest in heart failure.

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Outfitters, LLC, designates this live activity for a maximum of .5 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Note to Nurse Practitioners: Nurse practitioners can apply for AMA PRA Category 1 Credit^TM through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit(s)^TM from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. .5 contact hours (0.05 CEUs) Universal Activity Number:
0376-0000-17-012-H01-P

Type: knowledge-based

Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit^TM from organizations accredited by the Accreditation Council for Continuing Medical Education.

Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/TST21228 (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Lambert has no disclosures to report.

Dr. Leonard has no disclosures to report.

Jeffrey Helfand, DO, MS (peer reviewer) has no disclosures to report.

Kashemi D. Rorie, PhD (planning committee) has no disclosures to report. 



Jan Perez, CHCP (planning committee) has no disclosures to report.

Sharon Tordoff, CHCP (planning committee) has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: Nothing to Disclose

Unlabeled Use Disclosure

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.



Questions about this activity? Call us at 877.CME.PROS (877.263.7767).